Afya (NASDAQ:AFYA) Releases Quarterly Earnings Results

Key Points

• Afya beat quarterly EPS expectations, reporting $0.43 per share versus the $0.40 consensus estimate. Revenue totaled $187.8 million, slightly below analysts’ forecast of $189.62 million, while net margin was 20.20%.
• Shares rose 3.2% to $13.84 in Friday trading, giving the company a market capitalization of approximately $1.30 billion. The stock remains below its 52-week high of $16.50.
• Analyst sentiment remains cautious: six analysts rate Afya “Hold,” with a consensus price target of $18.00. Insiders have sold 87,745 shares worth about $1.31 million over the past 90 days.

Afya (NASDAQ:AFYA - Get Free Report) announced its quarterly earnings data on Friday. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03, FiscalAI reports. Afya had a return on equity of 17.94% and a net margin of 20.20%.The firm had revenue of $187.80 million during the quarter, compared to analysts' expectations of $189.62 million.

Afya Stock Up 3.2%

Shares of AFYA stock traded up $0.43 during midday trading on Friday, reaching $13.84. 168,637 shares of the stock were exchanged, compared to its average volume of 105,660. The firm has a market cap of $1.30 billion, a PE ratio of 9.05, a price-to-earnings-growth ratio of 1.45 and a beta of 0.34. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya has a 1 year low of $13.00 and a 1 year high of $16.50. The company's 50 day moving average is $14.27 and its two-hundred day moving average is $14.42.

Insider Buying and Selling

In other Afya news, VP Lelio De Souza Junior sold 36,204 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total transaction of $543,060.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Gomiero Mirella Basolli sold 10,000 shares of the firm's stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $14.80, for a total transaction of $148,000.00. Following the completion of the transaction, the vice president directly owned 34,530 shares of the company's stock, valued at approximately $511,044. The trade was a 22.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 87,745 shares of company stock valued at $1,314,175. Insiders own 0.80% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AFYA. Mangrove Partners IM LLC acquired a new stake in shares of Afya in the fourth quarter valued at $197,000. Susquehanna International Group LLP bought a new stake in Afya during the 3rd quarter worth approximately $419,000. Sei Investments Co. acquired a new position in shares of Afya during the 3rd quarter worth approximately $244,000. Lazard Asset Management LLC boosted its stake in Afya by 166.6% in the 2nd quarter. Lazard Asset Management LLC now owns 18,463 shares of the company's stock valued at $329,000 after purchasing an additional 11,537 shares during the period. Finally, Engineers Gate Manager LP acquired a new position in Afya during the 2nd quarter worth approximately $363,000. Institutional investors and hedge funds own 88.02% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AFYA. Wall Street Zen downgraded shares of Afya from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 2nd. Bank of America reiterated a "neutral" rating on shares of Afya in a research note on Thursday, June 11th. Weiss Ratings lowered shares of Afya from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday, July 31st. Zacks Research downgraded Afya from a "strong-buy" rating to a "hold" rating in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Afya from $21.50 to $21.00 and set a "neutral" rating for the company in a report on Monday, June 22nd. Six analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $18.00.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya's offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source